SynthesisFrontiers in psychiatry2025
The role of the amygdala in depression: a bibliometric analysis (2015-2024).
Synthesis in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Hypertension and frailty in older adults: a bibliometric analysis and knowledge mapping based on Web of Science, Scopus, and PubMed (1973-2025).Frontiers in medicine · 2026Pooled it
- Global research landscape, knowledge structure, and emerging trends in adverse childhood experiences and personality disorders: a bibliometric analysis.Frontiers in psychiatry · 2026Pooled it
- Global landscape, research hotspots, and evolutionary trends in childhood adversity and chronic disease research: a bibliometric analysis based on three databases.Frontiers in public health · 2026Pooled it
- Research trends and knowledge mapping of transcranial direct current stimulation in depression: a bibliometric study based on web of science, Scopus, and PubMed (2000-2025).Frontiers in psychiatry · 2026Pooled it
- Two-week prevalence and correlates of suicidal ideation among first-visit general-hospital psychiatric outpatients: a cross-sectional study using the PHQ-9 and EPQ.BMC psychiatry · 2026Article
- Bibliometric analysis of childhood adversity and anxiety disorders: Trends, hotspots and international collaboration.Global mental health (Cambridge, England) · 2026Article
- From synapse to system: mechanistic pathways of neural signaling dysfunction in psychiatric disorders.Frontiers in cell and developmental biology · 2026Review
- Research trends and potential molecular intersections between diabetic kidney disease and sarcopenia: a 21-year bibliometric and bioinformatics analysis.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression is a highly heterogeneous disorder with complex mechanisms. Given converging evidence implicating the amygdala in its pathophysiology, a systematic and quantitative synthesis is warranted to map the research landscape, hotspots, and emerging trends. Objective: To systematically characterize the research landscape of depression-amygdala studies from 2015 to 2024 using bibliometric and visualization analyses, identify core hotspots and emerging themes, and track their evolution to inform subsequent mechanistic research and precision interventions. Methods: Using data from the Web of Science Core Collection and Scopus (2015-2024), we conducted a bibliometric analysis of English-language publications on depression and the amygdala with Results: A total of 5,999 publications were included. Annual output increased steadily from 399 in 2015 to a peak of 831 in 2024. The United States (1,813, 30.2%), China (1,122, 18.7%), and Germany (357, 6.0%) were the top contributors. The ratio of multi-country publications (MCP) was highest for Germany (28.3%), followed by the United Kingdom (28.1%) and Canada (24.6%). At the institutional and journal levels, the University of California system, Harvard University, and Harvard Medical School ranked among the leading contributors. The international collaboration network exhibited a U.S.-centered structure, with frequent partnerships between the United States and China (n = 113), the United States and the United Kingdom (n = 86), and the United States and Germany (n = 81). Keyword co-occurrence and clustering analyses revealed four major thematic clusters: emotion regulation networks, biological signaling and regulation, developmental risk factors, and animal models. Overall, the field has evolved from region-specific studies toward network- and system-level integration, highlighting the amygdala's pivotal role in the neurobiological mechanisms of depression and its potential as a candidate neuromarker. Conclusion: Bibliometric evidence indicates that research on depression-amygdala relationships is moving toward multi-dimensional and cross-disciplinary integration. The amygdala's involvement in emotion regulation and early-life stress is increasingly recognized; alterations in its functional connectivity show promise as a neuromarker of depression, though clinical translation requires multi-center validation and standardized analytic workflows.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.